David W. Holden

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 63 publications

MAP4Ks drive cell death in response to Salmonella SpvB-induced actin depolymerization.

MAP4Ks drive cell death in response to Salmonella SpvB-induced actin depolymerization.

Journal: mBio

Published: May 20, 2026

Evaluating the feasibility of a remote sampling method for neurofilament light chain measurements in Multiple Sclerosis.

Evaluating the feasibility of a remote sampling method for neurofilament light chain measurements in Multiple Sclerosis.

Journal: Multiple sclerosis and related disorders

Published: April 13, 2026

Mammalian and bacterial adaptors function as co-disinhibitory pairs to activate the E3 ubiquitin ligase WWP2.

Mammalian and bacterial adaptors function as co-disinhibitory pairs to activate the E3 ubiquitin ligase WWP2.

Journal: The Journal of biological chemistry

Published: July 24, 2025

Effects of cladribine on intrathecal and peripheral B and plasma cells.

Effects of cladribine on intrathecal and peripheral B and plasma cells.

Journal: Clinical and experimental immunology

Published: September 04, 2024

Neurofilaments in neurologic disease.

Neurofilaments in neurologic disease.

Journal: Advances in clinical chemistry

Published: August 24, 2024

Cladribine tablets in relapsing-remitting multiple sclerosis preferentially target B-cells.

Cladribine tablets in relapsing-remitting multiple sclerosis preferentially target B-cells.

Journal: Clinical immunology (Orlando, Fla.)

Published: August 08, 2024

Modulation of Salmonella virulence by a novel SPI-2 injectisome effector that interacts with the dystrophin-associated protein complex.

Modulation of Salmonella virulence by a novel SPI-2 injectisome effector that interacts with the dystrophin-associated protein complex.

Journal: mBio

Published: June 21, 2024

Understanding the effectiveness and quality of virtual cancer multidisciplinary team meetings (MDTMs): a systematic scoping review.

Understanding the effectiveness and quality of virtual cancer multidisciplinary team meetings (MDTMs): a systematic scoping review.

Journal: BMC health services research

Published: June 18, 2024

A phase 2a open-label clinical trial to determine the effect of famciclovir on EBV activity as measured by EBV shedding in the saliva of patients with multiple sclerosis.

A phase 2a open-label clinical trial to determine the effect of famciclovir on EBV activity as measured by EBV shedding in the saliva of patients with multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: December 22, 2023

The Salmonella Typhi SPI-2 injectisome enigma.

The Salmonella Typhi SPI-2 injectisome enigma.

Journal: Microbiology (Reading, England)

Published: October 20, 2023

Changing from face-to-face to virtual meetings due to the COVID-19 pandemic: protocol for a mixed-methods study exploring the impact on cancer multidisciplinary team (MDT) meetings.

Changing from face-to-face to virtual meetings due to the COVID-19 pandemic: protocol for a mixed-methods study exploring the impact on cancer multidisciplinary team (MDT) meetings.

Journal: BMJ open

Published: April 19, 2023

Disease activity 4.5 years after starting cladribine: experience in 264 patients with multiple sclerosis.

Disease activity 4.5 years after starting cladribine: experience in 264 patients with multiple sclerosis.

Journal: Therapeutic advances in neurological disorders

Published: February 23, 2023

Showing 1-12 of 63

Last Updated: 09/26/2026